Rallybio Corporation (RLYB) Misses Q2 EPS by 30c
Tweet
Share
E-mailGet Alerts RLYB Hot Sheet
Join SI Premium – FREE
Rallybio Corporation (NASDAQ: RLYB) reported Q2 EPS of ($0.67), $0.30 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Smith & Wesson Brands (SWBI) Tops Q1 EPS by 13c
- Asana shares tumble on weak third quarter earnings outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
